Abstract
Background Transmission of respiratory pathogens such as SARS-CoV-2 depends on patterns of contact and mixing across populations. Understanding this is crucial to predict pathogen spread and the effectiveness of control efforts. Most analyses of contact patterns to date have focussed on high-income settings.
Methods Here, we conduct a systematic review and individual-participant meta-analysis of surveys carried out in low- and middle-income countries and compare patterns of contact in these settings to surveys previously carried out in high-income countries. Using individual-level data from 28,503 participants and 413,069 contacts across 27 surveys we explored how contact characteristics (number, location, duration and whether physical) vary across income settings.
Results Contact rates declined with age in high- and upper-middle-income settings, but not in low-income settings, where adults aged 65+ made similar numbers of contacts as younger individuals and mixed with all age-groups. Across all settings, increasing household size was a key determinant of contact frequency and characteristics, but low-income settings were characterised by the largest, most intergenerational households. A higher proportion of contacts were made at home in low-income settings, and work/school contacts were more frequent in high-income strata. We also observed contrasting effects of gender across income-strata on the frequency, duration and type of contacts individuals made.
Conclusions These differences in contact patterns between settings have material consequences for both spread of respiratory pathogens, as well as the effectiveness of different non-pharmaceutical interventions.
Funding This work is primarily being funded by joint Centre funding from the UK Medical Research Council and DFID (MR/R015600/1).
Competing Interest Statement
M.A. has received research funding from Seqirus outside the submitted work. G.E.P. was employed by the Emmes Company while analyzing the Niakhar Senegal social contact network data included in this study. The Emmes Company was contracted to perform data cleaning and data analysis of the Niakhar, Senegal clinical trial data (but not the social contact network data) for this study before G.E.P. joined the Emmes Company (in October 2015). After G.E.P. joined the Emmes Company, the sole support from Emmes for this manuscript was in the form of salary support for G.E.P.
Funding Statement
A.M. P.W., P.G.T.W. and C.W acknowledge joint Centre funding from the UK Medical Research Council and DFID (MR/R015600/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. O.J.W. acknowledges funding from the UK Foreign Commonwealth and Development Office. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. K.O.K acknowledges support by CUHK Direct grant for research (2019.020), Health and Medical Research Fund (reference number:?INF-CUHK-1, 17160302, 18170312), General Research Fund (reference number:?14112818), Early Career Scheme (reference number: 24104920) and Wellcome Trust (UK, 200861/Z/16/Z). P.J.D. was supported by a fellowship from the UK Medical Research Council (MR/P022081/1); this UK-funded award is part of the European and Developing Countries Clinical Trials Partnership 2 (EDCTP2) programme supported by the EU. E.F.G.N. holds an Australian Government Research Training Program Scholarship. F.M.R. receives funding from the Australian National Health and Medical Research Council, WHO, the Bill & Melinda Gates Foundation; Wellcome Trust, DFAT. Mélodie Monod acknowledges funding from the EPSRC through the EPSRC Centre for Doctoral Training in Modern Statistics and Statistical Machine Learning. G.E.P. was supported previously by General Medical Sciences / National Institute of Health U01-GM070749. GEP was employed by the Emmes Company while analyzing the Niakhar Senegal social contact network data included in this study. The Emmes Company was contracted to perform data cleaning and data analysis of the Niakhar, Senegal clinical trial data (but not the social contact network data) for this study before G.E.P. joined the Emmes Company (in October 2015). After G.E.P. joined the Emmes Company, the sole support from Emmes for this manuscript was in the form of salary support for G.E.P. J.D.S received funding for this work from the University of Washington and a grant from US National Institutes of Health, NIAID.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All data generated or analysed during this study are included in the manuscript and supporting files. Individual-level data across all studies and analysis code are available at https://github.com/mrc-ide/contact_patterns (see Supplementary Text 3 for data dictionary).
